BioCentury
ARTICLE | Company News

Ambit, Medarex antibody deal

November 19, 2001 8:00 AM UTC

Proteomics play Ambit Biosciences (San Diego, Calif.) and MEDX partnered to jointly develop and commercialize monoclonal antibodies. MEDX will contribute its UltiMAb Human Antibody Development System,...